Table 1. Association of socio demographic parameters of study participants and type of therapy with DILI.
| Efavirenz-based ART DILI | Hazard ratio (95%CI) | p-value | ||
| Cases = 65) | Cases = 65) | |||
| Sex | 0.001 | |||
| Female (%) | 39 (60.0) | 148 (51.4) | ||
| Male (%) | 26 (40.0) | 140 (58.6) | 0.43 (0.26–0.71) | |
| Body mass index | 0.09 | |||
| < = 18.5 (%) | 37 (56.3) | 132 (45.8) | ||
| >18.5 (%) | 28 (43.8) | 156 (54.2) | 0.66 (0.40–1.07) | |
| Hepatitis C virus antibody | 0.49 | |||
| Positive (%) | 1 (1.5.0) | 4 (1.4%) | ||
| Negative (%) | 64 (98.5) | 284 (98.6) | 0.68 (0.62–0.73) | |
| Hepatitis B surface antigen | 0.79 | |||
| Positive (%) | 5 (7.7) | 28 (9.7) | ||
| Negative (%) | 60 (92.3) | 260 (90.7) | 1.1 (0.46–2.76) | |
| Marital status | 0.51 | |||
| Married (%) | 21 (32.3) | 106 (36.8) | ||
| Divorced (%) | 11 (16.7) | 43 (14.9) | ||
| Single (%) | 22 (34.4) | 107 (37.3) | ||
| Widowed (%) | 11 (16.7 | 31 (10.9) | ||
| Type of HAART | 0.69 | |||
| D4T30/3TC/EFV (%) | 26 (40.4) | 98 (34.1) | ||
| CBV/EFV (%) | 23 (34.8) | 114 (39.6) | ||
| TDF/3TC/EFV (%) | 16 (24.8) | 76 (26.4) | ||